MyMilk
MyMilk: Empowering New families Through Innovation
MyMilk started as a lab-based breastmilk testing service to consumers and organizations and has evolved to focus on MyLee—an innovative milk sensing device and app that supports new mothers through breastfeeding challenges. MyLee helps establish milk supply, prevents challenges like inflammation, and promotes thriving outcomes for both mother and baby.
The MyLee technology is protected by a US patent, is FCC-approved and CE marked, and backed by published peer-reviewed research.
While not a medical device, MyLee is designed to directly support healthy breastfeeding and is FSA/HSA eligible.
MyMilk helps overcome the barriers to successful breastfeeding. Nearly every mother begins breastfeeding, but most face challenges in meeting their personal or healthcare-set goals, contributing to a global economic loss estimated at over $300 billion.
Batch 6
Ravid Shechter
Co-founder & Co-CEO
MyMilk
Ravid holds a Neuroimmunology PhD from the Weizmann Institute of Science, and a B.Sc in Biochemistry from the Technion. Ravid holds a deep understanding of breastfeeding and human milk bioanalytics, alongside unique market insights as a mom of two. Ravid participated in the steering committee of the Israeli national Human Milk bank that was established by MDA supported by the Israeli Ministry of Health. Ravid is an Invited reviewer in scientific journals in the field of human milk and lactation.